陈良龙,陆林祥,方军,鄢晓平,黄煜,李金国,孙旭东,钟玲

• 1:福建医科大学附属协和医院心内科福建省心脏医学中心福建省冠心病研究所

摘要(Abstract)：

目的初步探讨经胸超声心动图(TTE)替代经食管超声心动图(TEE)引导、无全身麻醉的改良经皮左心耳封堵术(PLAAO)的可行性及安全性。方法对14例符合入选标准的患者以TTE替代TEE引导、无全身麻醉进行PLAAO,术后定期临床随访,观察PLAAO相关主要不良事件。结果所有患者术中器械操作均获成功、无封堵相关严重并发症发生,即刻封堵成功率100%。住院及随访期间无PLAAO相关主要不良事件发生。本组14例患者改良局麻下TTE引导PLAAO患者手术时间及手术费用(不含麻醉及封堵器费用)分别为75~150(108±22)min及14601~33083(22491±5984)元。局麻患者较全身麻醉(全麻)患者每例节约麻醉费用960元。X线透视时间8~32(15.8±7.6)min。结论初步证实TTE替代TEE引导、无全身麻醉的改良PLAAO是安全有效的,这种方法简化了手术过程、有利于PLAAO的推广应用,但仍需更多病例加以验证。

关键词(KeyWords)： 经皮左心耳封堵术;经胸超声心动图;全身麻醉

Abstract:

Keywords:

基金项目(Foundation): 福建省医学创新课题资助计划(2014-CX-12)

作者(Author): 陈良龙,陆林祥,方军,鄢晓平,黄煜,李金国,孙旭东,钟玲

参考文献(References)：

• [1]Reddy VY,Doshi SK,Sievert H,et al.PROTECT AF investigators.percutaneous left atrial appendage closure for stroke prophylaxis in patients with atrial fibrillation:2.3-year follow-up of the PROTECT AF(watchman left atrial appendage system for embolic protection in patients with atrial fibrillation)trial.Circulation,2013,127(6):720-729.
• [2]苏晞.左心耳封堵治疗的现状和进展.中国介入心脏病学杂志,2016,24(8):458-461.
• [3]Wunderlich NC,Beigel R,Swaans MJ,et al.Percutaneous interventions for left atrial appendage exclusion:options,assessment,and imaging using 2D and 3D echocardiography.JACC Cardiovasc Imaging,2015,8(4):472-488.
• [4]Lip GY,Nieuwlaat R,Pisters R,et al.Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach:the euro heart survey on atrial fibrillation.Chest,2010,137(2):263-272.
• [5]Pisters R,Lane DA,Nieuwlaat R,et al.A novel user-friendly score(HAS-BLED)to assess 1-year risk of major bleeding in patients with atrial fibrillation:the Euro Heart Survey.Chest,2010,138(5):1093-1100.
• [6]Meier B,Blaauw Y,Khattab AA,et al.Document reviewers.EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion.Europace,2014,16(10):1397-1416.
• [7]中华医学会心电生理和起搏分会,中华医学会心血管病学分会,中国医师协会心律学专业委员会.左心耳干预预防心房颤动患者血栓栓塞事件:目前的认识和建议.中国心脏起搏与心电生理杂志,2014,18(4):471-486.
• [8]M9bius-Winkler S,Majunke N,Sandri M,et al.Percutaneous left atrial appendage closure:Technical aspects and prevention of periprocedural complications with the watchman device.World J Cardiol,2015,7(2):65-75.
• [9]Odell JA,Blackshear JL,Davies E,et al.Thoracoscopic obliteration of the left atrial appendage:potential for stroke reduction.Ann Thorac Surg,1996,6l:565-569.
• [10]Reddy VY,M9bius-Winkler S,Miller MA,et al.Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation:the ASAP study(ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).J Am Coll Cardiol,2013,61(25):2551-2556.
• [11]Reddy VY,Sievert H,Halperin J,et al.PROTECT AF steering committee and investigators.Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation:a randomized clinical trial.JAMA,2014,312(19):1988-1998.
• [12]Kirchhof P,Benussi S,Kotecha D,et al.2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS.Eur Heart J,2016,37(38):2893-2962.